MIBio 2024

We are delighted to announce that the 12th MIBio conference will take place at Howard Theatre, Downing College, Cambridge, on 04 December 2024.

MIBio engages leading experts from industry and academia in a discussion on how the latest molecular interaction-based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly, and safer therapeutic products.

The 2024 meeting will focus on a number of aspects of cutting edge biopharmaceutical product development, including patient-centric dosage forms, both from the formulation and from the device point of view. In addition, for the first time in the MIBio series, recent advances and future outlook in oral delivery will be discussed. Last but not least, presentations and discussions will cover development of novel dosage forms and the use of artificial intelligence to achieve better products.

We expect around 100 delegates from biopharma industry, academia and technology suppliers to create a stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation of formulation technologies. We will be inviting abstracts for poster submissions and welcome applications for sponsor and exhibitor slots on the day.

We look forward to seeing you at MIBio 2024!

MIBio Organising Committee

Jan Jezek | Arecor

Nicholas J Darton | AstraZeneca

Tejash Shah | GSK

Stephen Harding | University of Nottingham

Bernardo Perez-Ramirez | Sanofi

Bin Yang | AstraZeneca

Thank you to the support of The Royal Society of Chemistry